The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.
It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy.
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.
There was no upper age limit as data suggested it is likely to have a protective effect in older people.
At least six people die in coach fire in Switzerland
Trump says US destroyed mine-laying vessels after warning Iran
Britain working with allies to support shipping through Strait of Hormuz
Five Iranian women's soccer players granted humanitarian visas in Australia
Almost 700,000 displaced after Israeli strikes on Lebanon, UN agencies say
Iran fighting back but not stronger than U.S. thought, top U.S. general says
British warship HMS Dragon departs for Eastern Mediterranean
One dead, several injured in Iranian attack on Manama building
